Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

34171 Press Releases
DateTitleCompany
20 Jan 17 10x Genomics Invalidates RainDance Technologies Patent 10x Genomics, Inc.,
Published by
Business Wire
20 Jan 17 Infinity Presents Preclinical Data and Phase 1 Clinical Data on IPI-549 at PI3K Keystone Symposia Conference Infinity Pharmaceuticals, Inc.,
Published by
PR Newswire
20 Jan 17 NeuroMetrix, Inc. Announces Date for 2016 Full Year and Fourth Quarter Financial Results Conference Call NeuroMetrix, Inc.,
Published by
Business Wire
20 Jan 17 Additional Data Analyses From Phase IIb Trial of MIN-101 in Schizophrenia Underscore Benefit in Multiple Measurements of Cognitive Function Minerva Neurosciences, Inc.,
Published by
GlobeNewswire
20 Jan 17 The Role of Prunes in Bone Health International Nut & Dried Fruit Council (INC),
Published by
PR Newswire
20 Jan 17 DSG, Inc. Accelerates Growth with Opening of New Office in Bangalore, India DSG, Inc.,
Published by
Business Wire
20 Jan 17 Concert Pharmaceuticals Receives FDA Orphan Drug Designation for CTP-656 for the Treatment of Cystic Fibrosis Concert Pharmaceuticals, Inc.,
Published by
Business Wire
20 Jan 17 European Medicines Agency Validates Gilead’s Marketing Authorization Application for Investigational Chronic Hepatitis C Therapy Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) Gilead Sciences, Inc.,
Published by
Business Wire
20 Jan 17 ApolloMed Announces That APA ACO Has Been Selected By CMS As A Next Generation ACO Apollo Medical Holdings, Inc.,
Published by
PR Newswire
20 Jan 17 Synergy Pharmaceuticals’ TRULANCE™ (Plecanatide) Receives U.S. FDA Approval for the Treatment of Adults with Chronic Idiopathic Constipation Synergy Pharmaceuticals Inc.,
Published by
Business Wire
19 Jan 17 Novavax Initiates Phase 2 Safety and Immunogenicity Trial of the RSV F Vaccine in Older Adults Novavax, Inc.,
Published by
GlobeNewswire
19 Jan 17 Baxter to Present at the 6th Annual Leerink Partners Global Healthcare Conference Baxter International Inc.,
Published by
Business Wire
19 Jan 17 Charles River Laboratories Schedules Fourth-Quarter 2016 Earnings and 2017 Guidance Release and Conference Call Charles River Laboratories International, Inc.,
Published by
Business Wire
19 Jan 17 U.S. Patent & Trademark Office (USPTO) Issues Patent To Elorac, Inc. for Treating Chronic Inflammatory Disorders Elorac, Inc.,
Published by
Business Wire
19 Jan 17 Signature CEO Jan Vest to Retire; Schwartzkopf, Sackman Get Expanded Roles Signature Medical Group, Inc,
Published by
PR Newswire
19 Jan 17 Baxter’s Renal Therapy Services Significantly Reduced Peritonitis Infections among Home Dialysis Patients Baxter International Inc.,
Published by
Business Wire
19 Jan 17 GONITRO™ to Participate in First-of-its-Kind Comparative Effectiveness ISCHEMIA Clinical Trial Sponsored by the National Institutes of Health Espero Pharmaceuticals, Inc.,
Published by
Business Wire
19 Jan 17 Abeona Therapeutics Receives Orphan Drug Designation in The European Union for ABO-101 Gene Therapy in Sanfilippo Syndrome Type B Abeona Therapeutics Inc,
Published by
GlobeNewswire
19 Jan 17 Benefitfocus Wins Silver in the 2016 Brandon Hall Group Excellence Awards in Technology Benefitfocus, Inc.,
Published by
PR Newswire
19 Jan 17 TherapeuticsMD Announces Investor Day on March 1 TherapeuticsMD, Inc.,
Published by
Business Wire
19 Jan 17 Heron Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock Heron Therapeutics, Inc.,
Published by
Business Wire
19 Jan 17 Additional Data From BioTime’s OpRegen® Clinical Trial in Dry-AMD to be Presented at ARVO 2017 BioTime, Inc.,
Published by
Business Wire
19 Jan 17 ArmaGen Appoints Mathias Schmidt, Ph.D., as Chief Executive Officer ArmaGen, Inc.,
Published by
PR Newswire
19 Jan 17 AquaBounty Announces Completion of NASDAQ Listing and Equity Subscription from Intrexon AquaBounty Technologies, Inc.,
Published by
PR Newswire
19 Jan 17 North 6th Agency Unveils N6A Cannabis Services Group North 6th Agency, Inc.,
Published by
PR Newswire
19 Jan 17 IMBRUVICA® (ibrutinib) Approved by FDA for Marginal Zone Lymphoma (MZL) Patients Who Require Systemic Therapy and Have Received At Least One Prior Anti-CD20-Based Therapy Janssen Biotech, Inc.,
Published by
PR Newswire
19 Jan 17 Seattle Genetics to Host Conference Call and Webcast Discussion of Fourth Quarter and Year 2016 Financial Results on February 9, 2017 Seattle Genetics, Inc.,
Published by
Business Wire
19 Jan 17 Catabasis Pharmaceuticals Phase 1 Data on Edasalonexent (CAT-1004), a Potential Disease-Modifying Therapy Being Developed for Duchenne Muscular Dystrophy, Published in the Journal of Clinical Pharmacology Catabasis Pharmaceuticals, Inc.,
Published by
Business Wire
19 Jan 17 Medical Marijuana, Inc. Investment AXIM® Biotech Enters IBS Clinical Trial With CBD Chewing Gum Medical Marijuana, Inc.,
Published by
PR Newswire
19 Jan 17 Biocept Awarded Patent in Australia for the Use of Antibodies in Microchannels to Capture Circulating Tumor Cells and Other Rare Cells Biocept, Inc.,
Published by
PR Newswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.